New diagnostic markers in basal cell carcinoma

Area of Science:

• Biochemistry
• Dermatology
• Oncology

Background:

• Plasma lipoprotein levels are clinically significant for disease diagnosis and prognosis.
• Contradictory findings exist regarding blood lipoprotein levels in cancer patients.
• This study investigates lipid profiles in basal cell carcinoma (BCC) patients compared to healthy controls.

Purpose of the Study:

• To compare the lipid profiles of patients diagnosed with basal cell carcinoma (BCC) against those of healthy individuals.
• To evaluate the potential of lipid biomarkers in the diagnosis of BCC.
• To identify specific lipid alterations associated with BCC.

Main Methods:

• A case-control study involving 64 BCC patients and 64 healthy subjects.
• Blood plasma samples collected after an 8-12 hour fast.
• Lipid profiles analyzed using descriptive and analytical statistics; differences assessed with a two-sample t-test.

Main Results:

• Statistically significant differences observed in cholesterol (P=0.030) and high-density lipoprotein (HDL) (P<0.001) levels between BCC patients and controls.
• Mean HDL levels were significantly higher in BCC patients (61.98 ± 18.61 mg/dl) compared to controls (42.34 ± 7.83 mg/dl).
• Mean cholesterol levels were also higher in BCC patients (188.25 ± 38.90 mg/dl) versus controls (173.22 ± 38.79 mg/dl).

Conclusions:

• Alterations in lipid profiles, particularly cholesterol and HDL, may serve as a diagnostic marker for basal cell carcinoma (BCC).
• Further research is warranted to explore the utility of lipid profiles across different cancer types.
• Lipid profile changes could offer a novel approach to early cancer detection.